輸入代號或公司名稱後按 Enter
6574

霈方

+0.50 (+0.42%)最後更新 2026-09-16
台灣 · 上櫃 · 生技醫療業
120.0016成交張數9.03本益比2.46股價淨值比2.51%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入2025622年增 +6.5%
毛利率202557.1%最新一期
營業利益率202528.3%最新一期
每股盈餘20256.82年增 +66.3%
會計項目走勢201720182019202020212022202320242025
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計13.8%14.4%16.3%20.6%23.4%22.8%22.7%26.0%42.9%
營業毛利(毛損)86.2%85.6%83.7%79.4%76.6%77.2%77.3%74.0%57.1%
營業毛利(毛損)淨額86.2%85.6%83.7%79.4%76.6%77.2%77.3%74.0%57.1%
推銷費用62.1%66.6%67.7%65.3%68.3%61.1%59.2%49.3%18.6%
管理費用5.6%5.5%5.5%6.8%8.6%8.3%8.9%10.6%10.2%
研究發展費用0.1%0.1%0.2%0.2%0.4%0.4%0.3%0.4%0.1%
營業費用合計67.8%72.2%73.4%72.3%77.3%69.8%68.4%60.3%28.8%
營業利益(損失)18.4%13.4%10.3%7.1%-0.7%7.5%9.0%13.7%28.3%
利息收入0.3%0.2%0.2%0.8%1.1%0.9%
其他收入0.1%0.2%0.5%0.0%3.4%0.4%1.2%6.3%1.6%
其他利益及損失淨額-0.4%0.1%-0.1%-0.4%0.3%4.3%-1.2%-1.8%-0.2%
財務成本淨額0.1%0.1%0.4%0.5%0.3%0.3%0.5%
營業外收入及支出合計-0.3%0.4%0.3%-0.2%3.5%4.5%0.6%5.4%1.8%
稅前淨利(淨損)18.1%13.7%10.6%6.9%2.8%12.0%9.5%19.1%30.1%
所得稅費用(利益)合計3.1%2.7%2.2%1.9%0.7%1.8%1.8%3.6%6.0%
繼續營業單位本期淨利(淨損)15.0%11.0%8.4%5.0%2.1%10.2%7.7%15.5%24.1%
本期淨利(淨損)15.0%11.0%8.4%5.0%2.1%10.2%7.7%15.5%24.1%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益-0.3%0.6%2.7%19.5%
不重分類至損益之項目:-0.3%0.6%2.7%19.5%
國外營運機構財務報表換算之兌換差額-0.0%0.0%-0.0%0.0%0.0%0.0%-0.1%
與可能重分類之項目相關之所得稅-0.0%0.0%-0.0%0.0%0.0%0.0%-0.0%
後續可能重分類至損益之項目:-0.0%0.0%-0.0%0.0%0.0%0.0%-0.0%
其他綜合損益(淨額)-0.0%0.0%-0.0%-0.3%0.6%2.7%19.5%
本期綜合損益總額15.0%11.0%8.3%5.0%2.1%9.9%8.3%18.1%43.6%
母公司業主(淨利∕損)8.4%5.0%2.1%10.0%7.5%15.5%24.1%
母公司業主(綜合損益)8.3%5.0%2.1%9.7%8.1%18.1%43.6%
基本每股盈餘0.7%0.5%0.4%0.2%0.1%0.5%0.3%0.7%1.1%
繼續營業單位淨利(淨損)0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
稀釋每股盈餘0.7%0.5%0.4%0.2%0.1%0.5%0.3%0.7%1.1%
非控制權益(淨利∕損)-0.1%0.2%0.2%0.0%
非控制權益(綜合損益)-0.1%0.2%0.2%0.0%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。